News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • In the first ever randomized trial in the United States, researchers led by Dr. Wendy Chen will test whether aspirin helps women with breast cancer avoid recurrence and live longer.

Tags: BreastCancer

  • Dana-Farber has opened a mammography suite within the Whittier Street Health Center, located in Boston's Roxbury neighborhood.

Tags: BreastCancer, Disparities, Imaging

  • Dana-Farber is teaming up with Fitbit to test if weight loss can help prevent breast cancer recurrence among overweight women with early stage disease. This first of its kind study has potential to create a new standard of treatment for millions of breast cancer patients around the world.

Tags: BreastCancer, Exercise

  • Erica Mayer, MD, MPH, is a breast cancer expert at Dana-Farber. She says there are at least five simple ways women can reduce their risk of getting the disease.

Tags: BreastCancer, Genetics, Prevention

  • Breast cancer risk and prevention experts comment on new guidelines suggesting women ages 40 to 49 do not need regular breast cancer screenings.

Tags: BreastCancer

  • Practice-changing clinical research conducted at the Dana-Farber Cancer Institute Department of Biostatistics and Computational Biology was featured at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session.

Tags: BreastCancer, ProstateCancer

  • Researchers from Dana-Farber Cancer Institute will be presenting more than 70 studies at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 29 – June 2, 2015.

Tags: chemotherapy, BreastCancer

  • Kornelia Polyak, MD, PhD, and colleagues identified a network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors.

Tags: BreastCancer, Genomics

  • Younger women are more likely to be diagnosed with later-stage breast cancer, and treatment may affect fertility. Dana-Farber's specialized program addresses the unique needs of these patients.

Tags: BreastCancer

  • Dana-Farber investigators receive $13.3 million in funding to study whether some groups of patients with DCIS who do not benefit from standard treatment, could be effectively managed with surveillance alone.

Tags: BreastCancer

Showing 21-30 of 66 items